Found: 6
Select item for more details and to access through your institution.
Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1067749
- By:
- Publication type:
- Article
No association between use of angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID‐19 in the COvid MEdicaTion (COMET) study.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 8, p. 3301, doi. 10.1111/bcp.14751
- By:
- Publication type:
- Article
Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.753319
- By:
- Publication type:
- Article
Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e533, doi. 10.1093/cid/ciac495
- By:
- Publication type:
- Article
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48414-x
- By:
- Publication type:
- Article
Evaluation of a group-based online informed consent conversation (eConsent) in participants from a low-risk vaccination clinical trial.
- Published in:
- Trials, 2024, p. 1, doi. 10.1186/s13063-024-08367-4
- By:
- Publication type:
- Article